高纯度 Omega-3丨 白皮书 核心摘要： 在健康中国战略全面推进的背景下，国民健康管理意识显著提升，健康需求从 "被动治疗"向"主动预防"加 速转型。随着慢性病防控与亚健康改善成为全民健康的核心议题，膳食营养补充剂已成为全民健康管理的重 要工具，其市场发展与科学认知深化同步推进。基于这一现状，本白皮书旨在深入探讨高纯度 Omega-3 在中国居民健康管理中的作用及应用现状，加强公众对其生理功效的认知，为公众提供更加专业的营养指 导。白皮书从以下五个章节展开： 一、中国居民健康管理现状 国家政策推动全民健康管理向主动预防转型，面对慢性病年轻化与全周期防护挑战，需构建监测、干预与营 养支持体系。膳食营养补充剂通过定向支持和免疫力提升，成为公众践行主动健康管理的核心工具，助力实 现从治疗到预防的跨越。 二、膳食营养补充剂市场认知及应用表现 在国民健康管理需求升级与膳食营养补充剂市场快速发展的双轮驱动下，服用膳食营养补充剂已进阶为现代 人健康管理的核心方案。在消费者决策矩阵中，产品本身与品牌背书构成购买双引擎。但不同人群对成分需 求呈现差异化特征，折射精准健康管理趋势。 三、 Omega-3 产品与应用现状 Om ...

Group 1 - The company plans to publicly issue 50.01 million shares, accounting for 12.50% of the total share capital after issuance [1] - The strategic placement plan will participate in the subscription of up to 10% of the public offering scale, which is 5.01 million shares, with a total subscription amount not exceeding 50 million yuan [1] - The company is an international enterprise group specializing in the research, innovation, and industrialization of dietary nutritional supplements [1] Group 2 - The company's net profit attributable to the parent company for the years 2022 to 2024 is projected to be 142 million yuan, 160 million yuan, and 174 million yuan respectively [2] - The company expects a year-on-year revenue growth of approximately 15.03% to 27.36% for the first half of 2025, with net profit growth of about 8.56% to 19.20% [2] - The total planned investment for fundraising is approximately 603 million yuan, allocated to various projects including the construction of a nutritional health raw material production base and the expansion of production lines [2]

Group 1 - The core viewpoint of the article highlights that Tongrentang has been recognized for its groundbreaking research in precision nutrition, being the only dietary supplement company featured in the Nature supplement on global technology enterprises [1][4] - The article emphasizes that Tongrentang has gradually become a leading player in the global VDS (Vitamins, Dietary Supplements) industry, as evidenced by its repeated appearances in top international journals [4] Group 2 - Tongrentang's precision nutrition research has been notably recognized, including the establishment of China's first fully automated online dry blood spot testing center, which can detect over 40 metabolic components from a simple fingertip blood sample [5] - The company is collaborating with authoritative institutions to develop a new metabolic health assessment model, achieving breakthroughs in multi-dimensional quantification of homeostasis concepts [5] - The focus on scientific evidence is driving the transformation of research outcomes into public health benefits, with an emphasis on addressing common health issues through dietary supplements [6] Group 3 - Tongrentang has conducted significant research on the efficacy of red yeast rice and water-soluble tomato concentrate for cholesterol control and cardiovascular health [7] - The company has innovatively utilized a dual-layer tablet technology to enhance the effectiveness of composite vitamins and minerals [7] - Research has successfully isolated and studied several probiotic strains, exploring their potential benefits for digestive and metabolic health [8] Group 4 - Tongrentang has conducted the first large-scale real-world study in the field of bone and joint health, validating the safety and positive effects of long-term supplementation of glucosamine, chondroitin sulfate, and calcium [8] - The future of precision nutrition is expected to yield more research outcomes that will benefit public health, positioning Tongrentang at the forefront of this emerging field [8]

6月20日，民生健康（301507）接受东吴证券、建信养老机构调研，公司围绕民生健康发展历史、业务 架构、核心产品及民生医药控股集团业务板块等基础情况展开介绍，并就维生素矿物质、益生菌及治疗 型用药板块的最新经营动态等议题与调研机构进行深入交流并作出详细解答。 在治疗型OTC与医美领域的拓展上，民生健康展现清晰战略定力与充足发展信心。公司指出，民生健康 医美业务推进是深度响应药店渠道转型需求的主动作为，公司正通过在重点药店建设样板店、其他药店 柜台铺货的方式，实现全国范围的业务推广。公司推出的肌素然医美产品均为二类医疗器械类护肤产 品，涵盖医用修复膜、医用修复液、医用疤痕凝胶等，与普通日化产品形成本质差异，其中主推的医用 皮肤修复膜因添加酵母菌多肽且批文稀缺，能有效满足市场差异化需求；治疗型OTC业务作为公司重点 发展领域，凭借行业与产品的高进入壁垒，与现有渠道形成良好协同效应，成为公司业务拓展的重要支 撑。 公司主力产品21金维他多维元素片(21)开创国内维矿行业先河，以多规格包装全面覆盖线上线下 （300959）渠道，形成广泛人群覆盖。以维矿领域优势为基点，公司聚焦研发创新，深入洞察不同人 群、年龄及场景 ...

高纯度 Omega-3丨 白皮书 核心摘要： 在健康中国战略全面推进的背景下，国民健康管理意识显著提升，健康需求从 "被动治疗"向"主动预防"加 速转型。随着慢性病防控与亚健康改善成为全民健康的核心议题，膳食营养补充剂已成为全民健康管理的重 要工具，其市场发展与科学认知深化同步推进。基于这一现状，本白皮书旨在深入探讨高纯度 Omega-3 在中国居民健康管理中的作用及应用现状，加强公众对其生理功效的认知，为公众提供更加专业的营养指 导。白皮书从以下五个章节展开： 一、中国居民健康管理现状 国家政策推动全民健康管理向主动预防转型，面对慢性病年轻化与全周期防护挑战，需构建监测、干预与营 养支持体系。膳食营养补充剂通过定向支持和免疫力提升，成为公众践行主动健康管理的核心工具，助力实 现从治疗到预防的跨越。 二、膳食营养补充剂市场认知及应用表现 在国民健康管理需求升级与膳食营养补充剂市场快速发展的双轮驱动下，服用膳食营养补充剂已进阶为现代 人健康管理的核心方案。在消费者决策矩阵中，产品本身与品牌背书构成购买双引擎。但不同人群对成分需 求呈现差异化特征，折射精准健康管理趋势。 三、 Omega-3 产品与应用现状 Om ...

高纯度 Omega-3丨 白皮书 核心摘要： 在健康中国战略全面推进的背景下，国民健康管理意识显著提升，健康需求从 "被动治疗"向"主动预防"加 速转型。随着慢性病防控与亚健康改善成为全民健康的核心议题，膳食营养补充剂已成为全民健康管理的重 要工具，其市场发展与科学认知深化同步推进。基于这一现状，本白皮书旨在深入探讨高纯度 Omega-3 在中国居民健康管理中的作用及应用现状，加强公众对其生理功效的认知，为公众提供更加专业的营养指 导。白皮书从以下五个章节展开： 一、中国居民健康管理现状 国家政策推动全民健康管理向主动预防转型，面对慢性病年轻化与全周期防护挑战，需构建监测、干预与营 养支持体系。膳食营养补充剂通过定向支持和免疫力提升，成为公众践行主动健康管理的核心工具，助力实 现从治疗到预防的跨越。 二、膳食营养补充剂市场认知及应用表现 在国民健康管理需求升级与膳食营养补充剂市场快速发展的双轮驱动下，服用膳食营养补充剂已进阶为现代 人健康管理的核心方案。在消费者决策矩阵中，产品本身与品牌背书构成购买双引擎。但不同人群对成分需 求呈现差异化特征，折射精准健康管理趋势。 三、 Omega-3 产品与应用现状 Om ...

2025欧洲国际营养保健食品展(Vitafoods Europe)于5月20日-5月22日在西班牙巴塞罗那盛大举行，德国高端膳食营养品牌VIKPRO携贵妇护巢丸新品及明星爆 款产品亮相。 值得一提的是，展会期间，凭借卓越的市场表现和产品实力，VIKpro荣膺全球权威市场调研机构欧睿国际颁发的辅酶Q10(还原型)和槲皮素双项第一市场地 位认证，成为名副其实的销量品质双冠王！这不仅是对VIKPRO在膳食营养领域发展的肯定，更是对其产品品质和品牌价值的高度认可。 德国科研实力加码，锻造行业持续引领力 立足德国，辐射全球。VIKPRO自德国启航，以严谨专业的德国研发生产工艺，持续深耕全球营养健康市场。此次亮相Vitafoods Europe并一举蝉联欧睿国际 双第一市场地位认证，也是品牌向全球展现科技实力的重要一环。 VIKPRO一直以来都坚持细胞级根源养护的健康理念，以德国科技为依托，不断升级突破创新技术。基于此，VIKPRO与德国杜塞尔多夫医科大学达成战略 合作，并签约3D细胞级磷脂复合技术研究引领者Prof.Dr.Nicole Teusch作为品牌首席科学顾问，进一步整合顶尖学术资源，融合其在学术研究、临床检验 ...

2025年5月，艾瑞咨询从行业趋势、竞争格局、企业经营等方面对鱼油行业开展了专项研究与调 研，在研究市场上现有的鱼油产品后发现，WHC高纯鱼油脱颖而出。结合行业专家、电商数据 与行业洞察，艾瑞咨询对WHC高纯鱼油的市场地位展开了证明工作，并颁发了【WHC 高端高 纯度鱼油全国销量第一】市场地位证明书。 当前我国居民健康素养水平显著提升 我国居民健康素养在国家政策持续推动下显著提升，公众健康管理意识已从被动应对向主动预防转 变。当前健康管理需同步应对两大核心任务：一是遏制三高问题、心脑血管问题、糖尿病等慢性病 的高发态势及其年轻化趋势，二是构建覆盖全生命周期的疾病预防体系。遗传、环境与生活方式的 多维作用机制，决定了健康管理必须融合科学监测、行为干预和营养支持的综合策略。 科学服用膳食营养补充剂已成为精准营养管理的手段之一 在国民健康管理意识觉醒与膳食营养补充剂产业升级的双向驱动下，科学服用膳食营养补充剂已成 为现代人健康管理体系的重要支柱。整体来看，当前市场呈现显著的需求分层特征，不同人群的健 康管理需求各有侧重，这种差异化选择本质上反映了全民健康管理正在向个性化、精细化纵深发 展。 艾瑞咨询是艾瑞数智旗下品 ...

Core Insights - NYO3, a high-end dietary nutrition brand from Norway, marked a significant milestone in its global journey by showcasing its products during Norway's Constitution Day celebrations in May 2023 [1][2] Group 1: Brand Development and Product Launches - NYO3's new anti-aging product line, Ageless, featuring the "Aurora Skin Capsule," gained attention during the Constitution Day celebrations, receiving praise from Norwegian officials and celebrities, enhancing the brand's image as a "national gift" quality product [2] - At the Vitafoods Europe exhibition in Barcelona, NYO3 launched the "Emperor Amundsen Krill Oil," a product with high marine phospholipid content, and announced a strategic partnership with HBC to enter the salmon oil market with the first Norwegian wild salmon oil product [2] - NYO3 initiated a promotional campaign in Guangzhou in collaboration with Tmall International, focusing on the Asian market and launching a "90-day skin rejuvenation plan" [2] Group 2: Strategic Growth and Market Expansion - Since entering the Chinese market in 2019, NYO3 has adopted a "three-step strategy" to overcome challenges, including leveraging Norway's reputation for longevity, forming partnerships with research institutions, and establishing a quality trust system through rigorous testing [3] - The brand has successfully created a full lifecycle product matrix, with the Ageless oral beauty series becoming the top anti-aging brand in Northern Europe within a year of its launch [3] - NYO3's dual-channel approach combines online e-commerce and offline pharmacies to cater to diverse regional demands, expanding its reach across Europe, Asia-Pacific, and Australia [3] Group 3: Achievements and Recognition - In 2025, NYO3 was recognized as the leading brand in krill oil sales for two consecutive years by Euromonitor International, further solidifying its position as the "number one brand" in high-phospholipid krill oil [4] - The brand received accolades from Tmall International, including the "Outstanding Contribution Award" for Ageless, reinforcing its status as the leading anti-aging brand [4] - NYO3's commitment to quality and innovation has been acknowledged globally, with the brand being seen as a model for Norwegian companies expanding internationally [4] Group 4: Future Directions - NYO3 plans to continue its collaboration with top research institutions like the University of Oslo and NO-Age, focusing on oral anti-aging and salmon oil products to meet global consumer needs [5] - The company aims to leverage its Norwegian roots while expanding its global presence, emphasizing the concept of "health without borders" and driving innovation in the nutrition and health industry [5] - NYO3's journey from local to global exemplifies the cultural exchange between Norway and China, highlighting the brand's commitment to quality and user-driven innovation [5]

Core Insights - The Vitafoods Europe exhibition in Barcelona from May 20 to 22, 2025, serves as a global platform for the nutrition and health industry, showcasing innovations and future trends [1] - NYO3, a high-end dietary nutrition brand from Norway, emphasizes its commitment to quality and innovation, achieving multiple certifications and awards that reinforce its market leadership [3][4] Group 1: Product Innovation and Market Position - NYO3 has launched three strategic product lines: the high-end Omega-3 "Amundsen Series," the youth-focused "Monk Series," and the beauty-oriented "Ageless Series," with the Amundsen Series featuring a high-phospholipid krill oil product boasting an 80% phospholipid content [4] - The brand has received dual quality certifications from ORIVO, including "5 years of zero defects" and "3 years of gold standard quality," and has been recognized by Euromonitor as the leading global brand in krill oil sales for two consecutive years [3] Group 2: Global Expansion and Strategic Partnerships - NYO3 is expanding its global footprint, having established a presence in 21 countries and regions, including Europe, North America, and Southeast Asia, and is entering the Spanish market with products available in local pharmacies [6] - The company has announced a strategic partnership with HBC, a global leader in salmon functional ingredients, to enter the salmon oil market, further accelerating its globalization efforts [5] Group 3: Engagement in Sports Nutrition - NYO3 is actively entering the sports nutrition market, with its Amundsen krill oil product passing WADA doping tests, confirming its safety for athletes [9] - The brand has signed a partnership with Bryne FK, a football club, to become the exclusive Omega-3 nutritional supplement provider, highlighting its commitment to enhancing athletic performance [9][11] Group 4: Cultural Promotion and Brand Awareness - In celebration of Norway's Constitution Day, NYO3 launched a global giveaway campaign during the 618 shopping festival, promoting Norwegian culture and its health benefits associated with Omega-3 [10] - The company aims to leverage technological innovation and a global perspective to lead changes in the health industry, focusing on research and collaboration to provide effective and safe nutritional solutions [10]